Journal article
Does chemoimmunotherapy still have a role in CLL?: Chemoimmunotherapy with FCR is still an important option in CLL
PA Thompson, CS Tam
Oncology United States | UBM MEDICA | Published : 2018
DOI: 10.1159/000225079
Abstract
Effects of the SH inhibitor sodium iodoacetate, alone and with adjuncts menadiol diphosphate, sodium malonate, sodium fluoride and heparin, on incorporation of tryptophane-3 H into nonhistone chromosomal proteins of HeLa cells were examined. The drugs block incorporation of tryptophane-3 H into nonhistone chromosomal proteins far more than incorporation of leucine-3 H into total cellular proteins. Drug effects on thymidine phosphorylation and DNA synthesis in HeLa cells exceed corresponding effects on fibroblasts from normal healing wounds.
Grants
Funding Acknowledgements
Dr. Tam has received honoraria and research funding from AbbVie and Janssen. Dr. Thompson is an advisory board member and has received honoraria from Amgen, Genentech, and Pharmacyclics; he has also received honoraria from AbbVie.